The International Society for the Study of Emerging Drugs (ISSED) is established to unite the world’s multidisciplinary leaders on Novel Psychoactive Substances (NPS), emerging substances, and associated trends in regularized discourse, partnership and study, with a goal to develop innovative strategies for interventions, while counteracting the threat posed by NPS and emergent substances in society.

Through collaboration of international leaders working in the fields of medicine, public health, law enforcement, forensic sciences, drug policy, social sciences, and academia, commonalities in emergent trends and substances will be expediently identified, studied, and integrated into informed public health and public safety policy.


The ISSED archive includes the recordings of over 500 presentations on Novel Psychoactive Substances(NPS) from our previous conference series.

  • 500+ recorded talks on NPS

  • Downloadable presentation slides on NPS

  • Network with hundreds of professionals across the world on the ISSED HUB

  • Access resources via different platforms including mobile device

  • Gain discount on the ISSED journal’s open access fees



Executive Board

  • President – Professor Ornella Corazza (University of Hertfordshire; University of Trento)
  • Secretary – Dr Mariya Prilutskaya (Semey Medical University)
  • Treasurer – Dr Andres Roman-Urrestarazu (University of Cambridge)
  • International Relationships – Professor Olivier Rabin (World Anti-Doping Agency)
  • Training and Education – Professor Owen Bowden Jones (University College London)
  • Research – Professor Giuseppe Bersani (Sapienza University)
  • Toxicology – Professor Paul Dargan (King’s College London=
  • Early Career Network – Dr Attilio Negri (University of Milan)


Scientific Advisory Board

  • Dr Roumen Sedefov (The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
  • Dr Ana Gallegos (The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
  • Dr Justice Tettey (United Nations Office on Drugs and Crime)
  • Sabrina Levissianos (United Nations Office on Drugs and Crime)
  • Dr Irene Mazzoni (World Anti-Doping Agency)
  • Professor Fabrizio Schifano (University of Hertfordshire)
  • Professor Giovanni Martinotti (University of Chieti-Pescara)
  • Professor Johannes Ramaekers (Maastricht University)
  • Dr Noam Fast (Department of Defense, US Air Force)
  • Professor Balasingam Vicknasingam (Universiti Sains Malaysia)
  • Dr Ruri Kikura-Hanajiri (National Institute of Health Sciences)
  • Professor Francesco Botre’ (University of Lausanne)
  • Dr Antonio Metastasio (Camden and Islington NHS Trust)
  • Professor Matteo Marti (University of Ferrara)
  • Professor Gianluca Esposito (University of Trento)


To provide a platform for a multidisciplinary collaboration on NPS and other emergent substances.

To promote interdisciplinary study and research on NPS through collaborative publishing as well as rapid sharing of information on NPS identifications, usage trends, trafficking trends, change in policy and best practices on public health interventions, education and prevention activities

To promote interdisciplinary education and training programs on NPS and emergent substances


By joining ISSED, you will gain:

  • Access to private membership area with ISSED blog and information exchange
  • Networking with ISSED Members
  • Discounted access to the International Conference Series on Novel Psychoactive Substances, including FREE online access
  • Complementary access to the Online Archive with over 500 presentations on Novel Psychoactive Substances
  • Periodic Newsletter with latest news, opportunities for collaboration and events
  • 50% discount on open access charge for publications in the Journal of Emerging Trends in Drugs, Addictions and Health
  • Free passes to webinars and other training events

Annual Regular rate: £140

Annual Student rate: £100

(A valid student ID will need to be provided, please e-mail a scan/photo of your student ID to info@issed.net within 24 hours)

[simpay id="1570"]


Emerging Trends in Drugs, Addiction and Health (ETDAH)

Emerging Trends in Drugs, Addictions, and Health is the official journal of the ISSED. It is devoted to the rapid publication of authoritative papers on Novel Psychoactive Substances (NPS), Addictions and associated health phenomena. Read more and submit a paper!

Special issue of ETDAH – Call for papers

This Special Issue explores new drug and behavioural trends during the Covid-19 Pandemic. We welcome multidisciplinary contributions aimed at enhancing the understanding of how “physical distancing” and other radical changes in our life-styles might lead to the consumption of new emerging drugs and other risky behaviours.

The special issue is accepting submissions until August 15, 2021. Submissions will undergo the normal peer-review process by the journal and special issue is expected to be published in 2021.

Read more

Emerging Drugs in Sport (Hardback)

Olivier Rabin (editor), Ornella Corazza (editor)

Athletes are always aiming to be faster, better, stronger. New techniques to enhance their sporting performance have increasingly been linked to use of novel psychoactive substances (NPS) and other hard-to-detect substances like performance-enhancing drugs. This book offers a timely analysis of the new challenges posed by this phenomenon in the anti-doping community.

The authors present the first comprehensive perspective on the rapidly shifting doping scenario and reflect on use, regulation, policy, and market structure of NPS used in sports. They highlight the challenges with the list of prohibited substances and methods in and out of competition. They also evaluate how methods to detect new drugs present an ongoing battle for doping control as they have to be adapted constantly.

Pre-order on Waterstone

Novel Psychoactive Substances: Policy, Economics and Drug Regulation

In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it. It presents the first comprehensive overview of the international regulation, policy and market structure of the NPS phenomenon, offering a guide to inform legislative discussions and demonstrating from a comparative perspective the different approaches used to address the rise of NPS to date. It covers topics such as organized crime, drug markets, clinical evidence on NPS, and different regulatory approaches also in less explored settings such as prisons and sport environments.

Available on Amazon

Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS

Handbook of Novel Psychoactive Substances (NPS) provides a comprehensive overview of the challenges that clinicians face when dealing with NPS and discusses how the profile of patients and their socio-demographic characteristics frame the serious public health concern that NPS pose. It presents various clinical cases, as well as detailed accounts of symptoms, psychopathology, toxicity, and overall clinical management that NPS require. This handbook brings together a unique collection of chapters written by leading experts in the field, who have felt the need to share their knowledge and experience to improve the clinical practice on NPS and the wellbeing of their patients.

Available on Amazon

Club Drugs and Novel Psychoactive Substances: The Clinician’s Handbook (Royal College of Psychiatrists)

by Owen Bowden-Jones (Author), Dima Abdulrahim (Author)

Over the last decade many hundreds of new psychoactive drugs have emerged onto illicit markets. This flood of new drugs has led to clinicians being unsure of the rapidly emerging changing evidence base and uncertain of the best approaches to assessment and clinical management. This book provides a concise, accessible summary of these emerging drugs. By categorizing the hundreds of new drugs by their predominant psychoactive effect – sedative, stimulant and hallucinogenic – the book helps clinicians to manage a drug they are unfamiliar with by using their experience of other drugs with similar psychoactive properties. Written for clinicians from across the frontline, from A&E staff to drug treatment professionals, the authors draw on numerous clinical examples from their own clinical experiences to illustrate aspects of assessment and management. Club drugs and novel psychoactive substances will continue to challenge clinicians and this handbook provides readers with an invaluable introduction to this complex area.

Available on Amazon

The Drug Conversation: How to Talk to Your Child About Drugs Kindle Edition

by Owen Bowden-Jones

The Drug Conversation is a guide for parents about how to raise the thorny issue of drugs with their children. It will help you begin a useful conversation about drugs with your child.

This book provides information on the different types of drugs available, their attractions and harms, how they work in the brain, and who uses them and why. It covers issues such as how to detect drug use, drug testing, synthetic drugs (‘legal highs’), accessing help, effective treatments and what to expect from professional medical services.

All parents will need this book at some stage. It will help you to feel properly informed about drugs, more confident in talking to your child, more able to keep drug-related problems from developing and better equipped to tackle problems if they do arise.

Available on Amazon

Textbook of Clinical Management of Club Drugs and Novel Psychoactive Substances

Dima Abdulrahim, Programme Manager and Principal Researcher for the NEPTUNE Project, Central and North West London NHS Foundation Trust, Owen Bowden-Jones, Consultant Addiction Psychiatrist, Central and North West London NHS Foundation Trust

There are global concerns about the proliferation and misuse of club drugs and novel psychoactive substances, yet we know little about their harms and research on clinical management and treatment remains limited. This book fills the knowledge gap by providing a detailed overview of the research evidence available to date. The book provides a framework that allows readers to understand this large number of new drugs, using classifications based on primary psychoactive effect. Within this framework, the book provides detailed reviews of the more commonly used drugs. Each chapter explores pharmacology, patterns and mode of use, acute and chronic harms, and clinical interventions supported by research evidence. An invaluable resource for clinical staff, this book will support clinicians working in the emergency department, substance misuse and addiction services, mental health services, primary care, sexual health services and more. It will also be of interest to academics and those developing drug policy.

Coming soon